Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rigas

Showing results (21-30 of 782) with videos related to

Pageof 79
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|November 3, 2009
Pathogenesis and treatment of microalbuminuria in patients with diabetes: the road aheadRigas Kalaitzidis, George Bakris
Human Movement Science|January 17, 2002
A cheap telemetric system for analyzing gaitV Kyriazis, C Rigas
Clinical Biomechanics (Bristol, Avon)|May 30, 2002
Temporal gait analysis of hip osteoarthritic patients operated with cementless hip replacementV Kyriazis, C Rigas
British Journal of Cancer|February 7, 2008
Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancerB Rigas, Y Sun
Biochemical Society Transactions|July 27, 2005
Molecular targets of nitric-oxide-donating aspirin in cancerK Kashfi, B Rigas
Biochemical Society Transactions|July 27, 2005
Is COX-2 a 'collateral' target in cancer prevention?K Kashfi, B Rigas
International Journal of Oncology|June 15, 2006
NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review)Zhiquan Zhang, Basil Rigas
Diabetes, Obesity & Metabolism|June 13, 2009
Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockersRigas Kalaitzidis, George Bakris
International Journal of Oncology|December 22, 2007
The novel phenylester anticancer compounds: Study of a derivative of aspirin (phoshoaspirin)Basil Rigas, Vasiliki Kozoni
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2005
Cancer prevention: a new era beyond cyclooxygenase-2Basil Rigas, Khosrow Kashfi
Pageof 79

Showing results (21-30 of 782) with videos related to

Sort By:
Pageof 79
Journal of Clinical Hypertension (Greenwich, Conn.)|November 3, 2009
Pathogenesis and treatment of microalbuminuria in patients with diabetes: the road aheadRigas Kalaitzidis, George Bakris
Human Movement Science|January 17, 2002
A cheap telemetric system for analyzing gaitV Kyriazis, C Rigas
Clinical Biomechanics (Bristol, Avon)|May 30, 2002
Temporal gait analysis of hip osteoarthritic patients operated with cementless hip replacementV Kyriazis, C Rigas
British Journal of Cancer|February 7, 2008
Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancerB Rigas, Y Sun
Biochemical Society Transactions|July 27, 2005
Molecular targets of nitric-oxide-donating aspirin in cancerK Kashfi, B Rigas
Biochemical Society Transactions|July 27, 2005
Is COX-2 a 'collateral' target in cancer prevention?K Kashfi, B Rigas
International Journal of Oncology|June 15, 2006
NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review)Zhiquan Zhang, Basil Rigas
Diabetes, Obesity & Metabolism|June 13, 2009
Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockersRigas Kalaitzidis, George Bakris
International Journal of Oncology|December 22, 2007
The novel phenylester anticancer compounds: Study of a derivative of aspirin (phoshoaspirin)Basil Rigas, Vasiliki Kozoni
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2005
Cancer prevention: a new era beyond cyclooxygenase-2Basil Rigas, Khosrow Kashfi
Pageof 79